Holy Cross Hospital Approved to Perform New Transcatheter Heart Valve Replacement Procedure in Patients Who Cannot Undergo Open Heart Surgery
First ever artificial heart valve, recently approved by the Food and Drug Administration, can be implanted without major surgery
Holy Cross Hospital announced it is now approved to perform transcatheter heart valve replacement (TAVR) procedures in patients who cannot undergo open heart surgery utilizing a first-of-its-kind artificial heart valve that was approved by the Food and Drug Administration in November.
According to the FDA, approximately 300,000 patients in the U.S. experience valve deterioration, which means the heart must work harder to pump blood and that often leads to heart failure, blood clots and death. The new Edwards Lifesciences' Sapien heart valve can be threaded into place through a major artery that runs from the leg up to the heart. The device is approved only for patients who cannot have open heart surgery.
“This is a significant development in healthcare,” said Interventional Cardiologist Joshua Purow, M.D., of the Jim Moran Heart and Vascular Center and Research Institute at Holy Cross Hospital. “Some patients face many barriers to cardiac surgery for the replacement of valves whether it’s their age, co-morbidities or an inability to withstand rehabilitation. This new treatment option will change the lives of many patients.”
To accommodate transcatheter artificial heart valve implantations, Holy Cross constructed a new, 2,000-square-foo hybrid interventional operating room, one of the considerations that led to the hospital's approval from Edwards Lifesciences to perform the procedure.
"We designed the hybrid OR to provide the safest, optimal environment for high-risk patient procedures," said Holy Cross Hospital President and CEO Patrick A. Taylor, M.D. "Our newest space also advances our overall scope of surgical services and differentiates us from our competition."
The expansive operating room offers physicians advanced technology to perform leading-edge procedures, including endovascular stent (abdominal & thoracic), balloon valvuplasty, lead extraction, surgical cardiac ablation, bypass LAD with stent, and ASD & PFO closures.
Recognized as a leader in cardiac care, Holy Cross Hospital offers comprehensive cardiac services through the Jim Moran Heart and Vascular Center and progressive research at the Jim Moran Heart and Vascular Research Institute, which specializes in groundbreaking trials enabling its physicians to offer patients access to advanced clinical therapies that would otherwise not be available in the area.
The Jim Moran Heart and Vascular Center at Holy Cross Hospital, located at 4725 North Federal Highway in Fort Lauderdale, offers a wide array of diagnostic services including EKG, stress tests, Holter monitoring, tilt table testing, regular echocardiography, cardiac catheterization, peripheral angiography, peripheral vascular ultrasound and comprehensive electrophysiologic testing. For more information call (954) 229-7970.